- Home
- Publications
- Publication Search
- Publication Details
Title
Restoring TRAIL Mediated Signaling in Ovarian Cancer Cells
Authors
Keywords
TRAIL, Ovarian cancer, Apoptosis
Journal
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 62, Issue 6, Pages 459-474
Publisher
Springer Nature
Online
2014-07-16
DOI
10.1007/s00005-014-0307-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Telomere-Homologous G-Rich Oligonucleotides Sensitize Human Ovarian Cancer Cells to TRAIL-Induced Growth Inhibition and Apoptosis
- (2015) Sibaji Sarkar et al. Nucleic Acid Therapeutics
- Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa
- (2015) Michael J Ausserlechner et al. Oncotarget
- (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway
- (2014) Seung Hee Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Identification of SNP barcode biomarkers for genes associated with facial emotion perception using particle swarm optimization algorithm
- (2014) Li-Yeh Chuang et al. Annals of General Psychiatry
- Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis
- (2013) S. Liu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors
- (2013) Letícia da Conceição Braga et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Drug-SNPing: an integrated drug-based, protein interaction-based tagSNP-based pharmacogenomics platform for SNP genotyping
- (2013) C.-H. Yang et al. BIOINFORMATICS
- Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
- (2013) J H Huh et al. BRITISH JOURNAL OF CANCER
- KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression
- (2013) Z. Dong et al. CELL PROLIFERATION
- Aspidin BB, a phloroglucinol derivative, induces cell cycle arrest and apoptosis in human ovarian HO-8910 cells
- (2013) Yao Sun et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms
- (2013) Xiaoguang Li et al. CURRENT CANCER DRUG TARGETS
- NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells
- (2013) Pouneh Dokouhaki et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration
- (2013) Dongsheng Wang et al. FEBS Journal
- Survival factor NFIL3 restricts FOXO-induced gene expression in cancer
- (2013) M. Keniry et al. GENES & DEVELOPMENT
- Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma
- (2013) Koji Matsuo et al. GYNECOLOGIC ONCOLOGY
- Evaluation of Breast Cancer Susceptibility Using Improved Genetic Algorithms to Generate Genotype SNP Barcodes
- (2013) Cheng-Hong Yang et al. IEEE-ACM Transactions on Computational Biology and Bioinformatics
- Piceatannol Enhances Cisplatin Sensitivity in Ovarian Cancer via Modulation of p53, X-linked Inhibitor of Apoptosis Protein (XIAP), and Mitochondrial Fission
- (2013) Lee Farrand et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Induction of Apoptosis and Inhibition of Angiogenesis by PEGylated Liposomal Quercetin in Both Cisplatin-Sensitive and Cisplatin-Resistant Ovarian Cancers
- (2013) Qida Long et al. Journal of Biomedical Nanotechnology
- MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas
- (2013) Yu-Quan Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression
- (2013) Jung-Pil Lee et al. Journal of Gynecologic Oncology
- Genetic algorithm-generated SNP barcodes of the mitochondrial D-loop for chronic dialysis susceptibility
- (2013) Jin-Bor Chen et al. Mitochondrial DNA
- Preventive SNP–SNP interactions in the mitochondrial displacement loop (D-loop) from chronic dialysis patients
- (2013) Jin-Bor Chen et al. MITOCHONDRION
- Particle swarm optimization algorithm for analyzing SNP–SNP interaction of renin-angiotensin system genes against hypertension
- (2013) Shyh-Jong Wu et al. MOLECULAR BIOLOGY REPORTS
- Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity
- (2013) J.-W. Huang et al. MOLECULAR CANCER RESEARCH
- pERK 1/2 inhibit Caspase-8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner
- (2013) Ranadip Mandal et al. Molecular Oncology
- Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains
- (2013) Shan Li et al. NATURE
- A type III effector antagonizes death receptor signalling during bacterial gut infection
- (2013) Jaclyn S. Pearson et al. NATURE
- GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression
- (2013) Jonathan Chou et al. NATURE CELL BIOLOGY
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- Platelet-Derived Growth Factor Receptor Beta Serum Concentrations during First-Line Therapy in Ovarian Cancer
- (2013) Sabrina Mathey et al. ONCOLOGY
- MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer
- (2013) Michela Garofalo et al. PLoS One
- Novel Insights into the Synergistic Interaction of a Thioredoxin Reductase Inhibitor and TRAIL: The Activation of the ASK1-ERK-Sp1 Pathway
- (2013) Tingting Lin et al. PLoS One
- Huaier Aqueous Extract Inhibits Ovarian Cancer Cell Motility via the AKT/GSK3β/β-Catenin Pathway
- (2013) Xiaohui Yan et al. PLoS One
- MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
- (2013) Dengyu Chen et al. Journal of Ovarian Research
- Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
- (2013) J Cai et al. Oncogenesis
- Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway
- (2012) Archana Gopalan et al. CANCER LETTERS
- Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL
- (2012) H-C Chi et al. CELL DEATH AND DIFFERENTIATION
- The Importance of Integrating SNP and Cheminformatics Resources to Pharmacogenomics
- (2012) Hsueh-Wei Chang et al. CURRENT DRUG METABOLISM
- Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells
- (2012) Tamami Yasukagawa et al. FEBS LETTERS
- Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS–JNK–CHOP-mediated upregulation of death receptors
- (2012) Bokyung Sung et al. FREE RADICAL BIOLOGY AND MEDICINE
- PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma
- (2012) Pedro M. Costa et al. HUMAN MOLECULAR GENETICS
- High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
- (2012) Juliane Volkmann et al. INTERNATIONAL JOURNAL OF CANCER
- Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms
- (2012) Cheng-Hong Yang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
- (2012) Nadzeya Goncharenko-Khaider et al. Molecular Cancer
- Programmed Cell Death 4 (PDCD4) Enhances the Sensitivity of Gastric Cancer Cells to TRAIL-Induced Apoptosis by Inhibiting the PI3K/Akt Signaling Pathway
- (2012) Wei-Qiang Wang et al. Molecular Diagnosis & Therapy
- Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer
- (2012) Xiang Gao et al. Nanoscale
- A Small Molecule SMAC Mimic LBW242 Potentiates TRAIL- and Anticancer Drug-Mediated Cell Death of Ovarian Cancer Cells
- (2012) Eleonora Petrucci et al. PLoS One
- An Improved PSO Algorithm for Generating Protective SNP Barcodes in Breast Cancer
- (2012) Li-Yeh Chuang et al. PLoS One
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
- (2012) Christine Madsen et al. Journal of Ovarian Research
- Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?
- (2011) Yemliha Yildiz et al. Archives of Medical Science
- Guanylate Cyclase Activator YC-1 Enhances TRAIL-Induced Apoptosis in Human Epithelial Ovarian Carcinoma Cells via Activation of Apoptosis-Related Proteins
- (2011) Chung S. Lee et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells
- (2011) Jang-Chang Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model
- (2011) Kerri S. Bevis et al. GYNECOLOGIC ONCOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2
- (2011) Kyoung-jin Min et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins
- (2011) Yun Jeong Kim et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- PDGF induced microRNA alterations in cancer cells
- (2011) Minghai Shao et al. NUCLEIC ACIDS RESEARCH
- Computational Analysis of Simulated SNP Interactions Between 26 Growth Factor-Related Genes in a Breast Cancer Association Study
- (2011) Cheng-Hong Yang et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- αB-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells
- (2010) Dorota Goplen et al. AMERICAN JOURNAL OF PATHOLOGY
- NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL
- (2010) Cigdem Aydin et al. BMC CANCER
- Functional implication of TRAIL −716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor
- (2010) Ranjana Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L
- (2010) Hong Zhu et al. CANCER LETTERS
- DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8
- (2010) Satoshi Kurita et al. CANCER SCIENCE
- Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo
- (2010) Xia Zhang et al. CANCER SCIENCE
- Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation
- (2010) M Ehrenschwender et al. CELL DEATH AND DIFFERENTIATION
- A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5
- (2010) Y. Huang et al. ENDOCRINE-RELATED CANCER
- Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression
- (2010) Weiqiang Wang et al. EXPERIMENTAL CELL RESEARCH
- The role of c-FLIPL in ovarian cancer: Chaperoning tumor cells from immunosurveillance and increasing their invasive potential
- (2010) Ahmed El-Gazzar et al. GYNECOLOGIC ONCOLOGY
- A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells
- (2010) Christian D. Fingas et al. HEPATOLOGY
- Effect of TRA-8 Anti-Death Receptor 5 Antibody in Combination With Chemotherapy in an Ex Vivo Human Ovarian Cancer Model
- (2010) Peter J. Frederick et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway
- (2010) Chung Soo Lee et al. INVESTIGATIONAL NEW DRUGS
- Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5
- (2010) Young-Hwa Jung et al. LIFE SCIENCES
- Enhancer of Zeste Homolog 2 Promotes the Proliferation and Invasion of Epithelial Ovarian Cancer Cells
- (2010) H. Li et al. MOLECULAR CANCER RESEARCH
- MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition In vivo
- (2010) R. K. Srivastava et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers
- (2010) J S Imam et al. ONCOGENE
- Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway
- (2009) Soo-Jung Park et al. BIOCHEMICAL PHARMACOLOGY
- Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation
- (2009) Jin Yeop Kim et al. CARCINOGENESIS
- sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease
- (2009) Xiaohua Yan et al. IMMUNOGENETICS
- R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-κB pathway
- (2009) Michela Festa et al. INTERNATIONAL JOURNAL OF CANCER
- Combinational Polymorphisms of Seven CXCL12-Related Genes Are Protective against Breast Cancer in Taiwan
- (2009) Gau-Tyan Lin et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- miR-200 Regulates PDGF-D-Mediated Epithelial-Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells
- (2009) Dejuan Kong et al. STEM CELLS
- A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies
- (2008) S. J. Hotte et al. CLINICAL CANCER RESEARCH
- Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPSdown-regulation
- (2008) Jin Yeop Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Odds Ratio-Based Genetic Algorithms for Generating SNP Barcodes of Genotypes to Predict Disease Susceptibility
- (2008) Hsueh-Wei Chang et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Soluble receptor-mediated selective inhibition of VEGFR and PDGFR signaling during physiologic and tumor angiogenesis
- (2008) F. Kuhnert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of C-kit and Platelet-Derived Growth Factor Receptors in Ovarian Granulosa Cell Tumors
- (2008) Rodney P. Rocconi et al. Reproductive Sciences
- Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma
- (2007) Ismail T. Koksal et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now